Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs.
2016 ◽
Vol 34
(15_suppl)
◽
pp. e23025-e23025
2018 ◽
Vol 21
(3)
◽
pp. 411-418
◽
2015 ◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. e17063-e17063
2016 ◽
2020 ◽
2019 ◽